These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Synergistic activities of an efflux pump inhibitor and iron chelators against Pseudomonas aeruginosa growth and biofilm formation. Liu Y; Yang L; Molin S Antimicrob Agents Chemother; 2010 Sep; 54(9):3960-3. PubMed ID: 20566773 [TBL] [Abstract][Full Text] [Related]
65. Resistance to bile salts and sodium deoxycholate in macrolide- and fluoroquinolone-susceptible and resistant Campylobacter jejuni and Campylobacter coli strains. Mavri A; Smole Možina S Microb Drug Resist; 2013 Jun; 19(3):168-74. PubMed ID: 23289436 [TBL] [Abstract][Full Text] [Related]
66. Activity of OP0595/β-lactam combinations against Gram-negative bacteria with extended-spectrum, AmpC and carbapenem-hydrolysing β-lactamases. Livermore DM; Mushtaq S; Warner M; Woodford N J Antimicrob Chemother; 2015 Nov; 70(11):3032-41. PubMed ID: 26311835 [TBL] [Abstract][Full Text] [Related]
67. New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship. Jean SS; Gould IM; Lee WS; Hsueh PR; Drugs; 2019 May; 79(7):705-714. PubMed ID: 30972660 [TBL] [Abstract][Full Text] [Related]
68. Role of the AheABC efflux pump in Aeromonas hydrophila intrinsic multidrug resistance. Hernould M; Gagné S; Fournier M; Quentin C; Arpin C Antimicrob Agents Chemother; 2008 Apr; 52(4):1559-63. PubMed ID: 18268083 [TBL] [Abstract][Full Text] [Related]
69. Role of Efflux Pump-Mediated Antibiotic Resistance in Quorum Sensing-Regulated Biofilm Formation by Dawan J; Li Y; Lu F; He X; Ahn J Pathogens; 2022 Jan; 11(2):. PubMed ID: 35215091 [TBL] [Abstract][Full Text] [Related]
70. Effect of efflux pump inhibition on Pseudomonas aeruginosa transcriptome and virulence. Rampioni G; Pillai CR; Longo F; Bondì R; Baldelli V; Messina M; Imperi F; Visca P; Leoni L Sci Rep; 2017 Sep; 7(1):11392. PubMed ID: 28900249 [TBL] [Abstract][Full Text] [Related]
71. AmpG inactivation restores susceptibility of pan-beta-lactam-resistant Pseudomonas aeruginosa clinical strains. Zamorano L; Reeve TM; Juan C; Moyá B; Cabot G; Vocadlo DJ; Mark BL; Oliver A Antimicrob Agents Chemother; 2011 May; 55(5):1990-6. PubMed ID: 21357303 [TBL] [Abstract][Full Text] [Related]
72. Sensitivity of Escherichia coli to various beta-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic beta-lactamases: a quantitative predictive treatment. Nikaido H; Normark S Mol Microbiol; 1987 Jul; 1(1):29-36. PubMed ID: 3330755 [TBL] [Abstract][Full Text] [Related]
73. Efflux-pump inhibitory activity of a gallotannin from Terminalia chebula fruit against multidrug-resistant uropathogenic Escherichia coli. Bag A; Chattopadhyay RR Nat Prod Res; 2014; 28(16):1280-3. PubMed ID: 24620744 [TBL] [Abstract][Full Text] [Related]
74. Proof of an Outer Membrane Target of the Efflux Inhibitor Phe-Arg-β-Naphthylamide from Random Mutagenesis. Schuster S; Bohnert JA; Vavra M; Rossen JW; Kern WV Molecules; 2019 Jan; 24(3):. PubMed ID: 30699887 [TBL] [Abstract][Full Text] [Related]
75. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli. Kern WV; Steinke P; Schumacher A; Schuster S; von Baum H; Bohnert JA J Antimicrob Chemother; 2006 Feb; 57(2):339-43. PubMed ID: 16354747 [TBL] [Abstract][Full Text] [Related]
76. Role of efflux pump inhibitor in decreasing antibiotic cross-resistance of Pseudomonas aeruginosa in a burn hospital in Iran. Talebi-Taher M; Majidpour َ; Gholami A; Rasouli-Kouhi S; Adabi M J Infect Dev Ctries; 2016 Jun; 10(6):600-4. PubMed ID: 27367008 [TBL] [Abstract][Full Text] [Related]
78. Resistance of Pseudomonas aeruginosa to new beta-lactamase-resistant beta-lactams. Godfrey AJ; Bryan LE Antimicrob Agents Chemother; 1984 Oct; 26(4):485-8. PubMed ID: 6440472 [TBL] [Abstract][Full Text] [Related]
79. Beta-lactamases identified in clinical isolates of Pseudomonas aeruginosa. Zhao WH; Hu ZQ Crit Rev Microbiol; 2010 Aug; 36(3):245-58. PubMed ID: 20482453 [TBL] [Abstract][Full Text] [Related]
80. Ceftazidime-avibactam activity against a challenge set of carbapenem-resistant Enterobacterales: Ompk36 L3 alterations and β-lactamases with ceftazidime hydrolytic activity lead to elevated MIC values. Castanheira M; Doyle TB; Hubler C; Sader HS; Mendes RE Int J Antimicrob Agents; 2020 Jul; 56(1):106011. PubMed ID: 32417206 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]